<p><sup>a</sup>Adjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, diabetes mellitus.</p><p><sup>b</sup>False positive discovery rate (FDR)-adjusted <i>P</i>-value.</p><p>The combination of the polymorphisms of microRNA machinery genes in CRC patients and controls: male subgroup.</p
<p>Odds ratios for CRC risk by <i>KRAS</i> and <i>BRAF</i> mutation status per allele of the <i>CTH<...
<p>Distribution of microRNA gene genetic variants and Odds ratio with 95% CI in breast cancer patien...
1<p>n: number of individuals with the respective polymorphism.</p>2<p>p-value: derived from Pearson ...
<p><sup>a</sup>Adjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, ...
<p><sup>a</sup>Adjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, ...
<p>Genotype frequencies of microRNA machinery genes polymorphism and HCC patients survival based on ...
<p><sup>a</sup>Data were calculated by unconditional logistic regression, adjusted for age, sex, BMI...
<p>Allele combination analysis of microRNA machinery gene polymorphism in HCC patients and control s...
<p>Association between microRNAs and CRC recurrence of the stage II and III CRC patients in the diff...
polymorphisms (SNPs) with the risk of CRC using a hospital-based case–control design with as associa...
<p><sup>1</sup>n: number of individuals with the respective polymorphism.</p><p>2 p-value: derived f...
<p><sup>1</sup>n: number of individuals with the respective polymorphism.</p><p>2 p-value: derived f...
<p>Genotype/allele frequencies of rs3834129 SNP in COGENT consortium cohorts and risk of CRC (logist...
<p>RCC, renal cell carcinoma; OR, odds ratio; 95% CI, 95% confidence interval</p><p>Genetic prolifer...
and colorectal cancer.We selected 12 case-control studies involving 11,769 cases of CRC and 14,328 ...
<p>Odds ratios for CRC risk by <i>KRAS</i> and <i>BRAF</i> mutation status per allele of the <i>CTH<...
<p>Distribution of microRNA gene genetic variants and Odds ratio with 95% CI in breast cancer patien...
1<p>n: number of individuals with the respective polymorphism.</p>2<p>p-value: derived from Pearson ...
<p><sup>a</sup>Adjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, ...
<p><sup>a</sup>Adjusted odds ratio on the basis of risk factors, such as age, gender, hypertension, ...
<p>Genotype frequencies of microRNA machinery genes polymorphism and HCC patients survival based on ...
<p><sup>a</sup>Data were calculated by unconditional logistic regression, adjusted for age, sex, BMI...
<p>Allele combination analysis of microRNA machinery gene polymorphism in HCC patients and control s...
<p>Association between microRNAs and CRC recurrence of the stage II and III CRC patients in the diff...
polymorphisms (SNPs) with the risk of CRC using a hospital-based case–control design with as associa...
<p><sup>1</sup>n: number of individuals with the respective polymorphism.</p><p>2 p-value: derived f...
<p><sup>1</sup>n: number of individuals with the respective polymorphism.</p><p>2 p-value: derived f...
<p>Genotype/allele frequencies of rs3834129 SNP in COGENT consortium cohorts and risk of CRC (logist...
<p>RCC, renal cell carcinoma; OR, odds ratio; 95% CI, 95% confidence interval</p><p>Genetic prolifer...
and colorectal cancer.We selected 12 case-control studies involving 11,769 cases of CRC and 14,328 ...
<p>Odds ratios for CRC risk by <i>KRAS</i> and <i>BRAF</i> mutation status per allele of the <i>CTH<...
<p>Distribution of microRNA gene genetic variants and Odds ratio with 95% CI in breast cancer patien...
1<p>n: number of individuals with the respective polymorphism.</p>2<p>p-value: derived from Pearson ...